Mount Sinai Deploys AI Model to Improve Delirium Detection

An artificial intelligence (AI) model developed by researchers at the Icahn School of Medicine at Mount Sinai improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium, according to a new study.

 The model identifies patients at high risk for delirium and alerts a specially trained team to assess the patient and create a treatment plan, if needed. It has been integrated into hospital operations, helping providers identify and manage delirium, a condition that can affect up to one-third of hospitalized patients.

The AI tool significantly improved monthly delirium detection rates—from 4.4 to 17.2 percent—allowing for earlier intervention. Patients identified also received lower doses of sedative medications, potentially reducing side effects and improving overall care.

The study, the first to show that an AI-powered delirium risk assignment model can not only perform well in a laboratory setting but also deliver real-world benefits in clinical practice, was published in the May 7, 2025 online issue of JAMA Network Open.

As the Mount Sinai researchers explain, delirium is a sudden and severe state of confusion that carries life-threatening risks and often goes undetected in hospitalized patients. Without treatment, it can prolong hospital stays, raise mortality risk, and worsen long-term outcomes. Until now, AI-driven delirium prediction models have struggled to demonstrate tangible improvements in patient care, say the investigators.

"The motivation behind our study at Mount Sinai was clear. Current AI-based delirium prediction models haven’t yet shown real-world benefits for patient care," said senior corresponding study author Joseph Friedman, M.D., in a statement.  He is founder and director of Delirium Services for the Mount Sinai Health System and Professor of Psychiatry and Neuroscience, at the Icahn School of Medicine at Mount Sinai. "We wanted to change that by creating a model that accurately calculates delirium risk in real time and integrates smoothly into clinical workflows, helping hospital staff catch and treat more patients with delirium who might otherwise be overlooked," he said.

Rather than building an AI model in isolation and testing it later in hospitals, the research team worked closely with Mount Sinai clinicians and hospital staff from the start. This "vertical integration" approach allowed them to refine the model in real time, ensuring it was both effective and practical for clinical use.

When deployed at Mount Sinai, the AI model dramatically improved delirium detection, resulting in:
• A 400 percent increase in identified cases without increasing time spent screening patients;
• Safer prescribing by reducing the use of potentially inappropriate medications in older adults; and
• Strong, reliable performance in a real-world hospital setting.

In their study, which involved more than 32,000 patients admitted to The Mount Sinai Hospital in New York City, the researchers used the AI model to analyze a combination of structured data and clinicians’ notes from electronic health records. It used machine learning to identify chart data patterns associated with a high risk of delirium and applied natural language processing to identify patterns from the language of chart notes written by hospital staff. This approach captures staff observations of subtle mental status changes in patients who are delirious or at heightened risk. An individual staff member writing a note may be unaware at that time that their clinical observations are helping to improve the AI model’s accuracy.

The model was tested in a highly diverse patient population with a wide range of medical and surgical conditions—far broader than the narrow groups typically included in studies of machine learning-based delirium risk prediction models. 

“Our model isn’t about replacing doctors—it’s about giving them a powerful tool to streamline their work,” added Friedman. “By doing the heavy lifting of analyzing vast amounts of patient data, our machine learning approach allows health care providers to focus their expertise on diagnosing and treating patients more effectively and with greater precision.”

While the AI model has delivered strong results at The Mount Sinai Hospital, and testing is underway at other Mount Sinai locations, validation will be needed at other hospital systems to evaluate its performance in different settings and adjust if needed.